Retrovirology

official impact factor 5.24

This article is part of the supplement: 2005 International Meeting of The Institute of Human Virology

Open Access Poster presentation

7he MHC Class II Transactivator (CIITA): A Physiologic Inhibitor of HTLV-2 Retroviral Infection

Giovanna Tosi1, Elisabetta Pilotti2, Andrea DL Barbaro1, Lorenzo Mortara1, Claudio Casoli2 and Roberto S Accolla1*

Author Affiliations

1 Department of Clinical and Biological Sciences, University of Insubria, 21100 Varese, Italy

2 Department of Clinical Medicine, Nephrology, and Prevention, University of Parma, Parma, Italy

For all author emails, please log on.

Retrovirology 2005, 2(Suppl 1):P5 doi:10.1186/1742-4690-2-S1-P5

Published: 8 December 2005

First paragraph (this article has no abstract)

The transcriptional activator CIITA is the master regulator of the expression of MHC class II genes. In addition to this major role, we have found that CIITA exerts an important inhibitory effect on the HTLV-2 replication, similar to our previously decribed effect on the HIV-1 replication. This inhibition is mediated by the N-terminal 1–321 region where we identified a minimal fragment of 80 aminoacids that specifically blocks the activity of the viral transactivator Tax2. This fragment does not inhibit the function of Tat, the transcriptional activator of HIV-1.